Trajan Group (TRJ) AGM 2024 summary

Opening remarks and agenda

• Meeting opened with acknowledgment of traditional custodians and a welcome to shareholders, directors, and auditors, chaired by John Eales AM at the virtual AGM on 29 October 2024.

• Instructions provided for online participation, voting, and Q&A.

• Agenda included procedural guidelines, business update, formal business, and an industry trends presentation.

Financial performance review

• First half of the year impacted by industry-wide destocking, with a strong rebound in the second half.

• Revenue achieved within 5% of target; second-half EBITDA increased by over 50%.

• Q1 net revenue up high-single-digit over prior year; components and consumables up 4%, capital equipment up 15%.

• Pharma-related capital equipment down 30% in Q1, but food-related business growth offset this.

• Full-year revenue guidance reaffirmed at AUD 160–165 million, normalized EBITDA at AUD 17–19 million.

• Annual Financial Report, Directors' Report, and Audit Report for the year ended 30 June 2024 presented.

Board and executive committee updates

• Directors and executive team introduced, including John Eales (Chair), Stephen Tomisich (CEO), Robert Lyon, Tiffiny Lewin, Sara Watts, and Dr Rohit Khanna.

• CEO Stephen Tomisich delivered a presentation to shareholders.

• Dr Rohit Khanna discussed emerging trends and opportunities in the OEM and life sciences sector.

• Board expressed confidence in management and acknowledged shareholder support.